1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
Book a demo
-
  1. My Preqin
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch
  1. My Preqin
Book a demo

EpiVax Oncology, Inc.

Have updates for this profile?  Please contribute data

About
= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

New York NY US

Primary Industry

Healthcare Specialists

About

Founded in 2017 and based in New York, US, EpiVax Oncology, Inc. operates as a biotechnology company that focuses on the development of cancer immunotherapies and personalized therapeutic vaccines. The company also utilizes genetic profiling in developing these neo-epitope based therapeutic vaccines.
Current Investors
5Y Capital, NextWaveBio, Horatio Ventures

Request a demo to show more

Primary Industry
Healthcare Specialists
Sub Industries
Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Oncology/Cancer Treatment
Website
www.epivaxonco.com
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.
Sign in Request demo